Immune System News and Research

RSS

New recombinant antibody can recognize MSCs in umbilical cord blood

A new recombinant antibody can detect and isolate mesenchymal stem cells (MSCs), a nonembryonic source of stem cells with promising applications in tissue engineering, blood stem cell transplantation, and treatments for immune-mediated disorders.

4 Sep 2013

UCLA researchers receives $13M Early Translational grants to advance innovative discoveries using stem cells

Four researchers from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have received Early Translational Research Awards totaling approximately $13 million from the California Institute for Regenerative Medicine, the state's stem cell agency. The UCLA researchers received four of the 12 total awards; no other institution received more than one.

4 Sep 2013

Cangene Signs Up To $77M Contract Extension With CDC

...

3 Sep 2013

Cangene Inks Up To $77M Contract Extension With CDC

...

3 Sep 2013

Chronic granulomatous disease (CGD) research: an interview with Dr. Griffin Rodgers, NIDDK director

Chronic granulomatous disease, or CGD, is a diverse group of inherited diseases in which certain cells of the immune system have difficulty forming reactive oxygen compounds, most importantly superoxide radicals. These are used by these white blood cells to kill certain bacteria.

3 Sep 2013

VolitionRx-led consortium receives grant to develop novel NuQ biomarkers for immune response

...

3 Sep 2013

Viralytics releases financial results for 2013

Viralytics Limited (ASX:VLA, OTCQX:VRACY) has released its financial results for the year ended 30 June 2013.

3 Sep 2013

Apitope successfully completes ATX-MS-1467 Phase I trial in relapsing MS patients with positive results

Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announced completion with positive results of its second Phase I clinical trial of ATX-MS-1467.

3 Sep 2013

Imaxio's pro-immunogenic technology used in tuberculosis vaccine phase I clinical study

Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.

3 Sep 2013

Research shows how mucosal surfaces in body respond to C. albicans to prevent damage

Candida albicans is a common fungus found living in, and on, many parts of the human body. Usually this species causes no harm to humans unless it can breach the body's immune defences, where can lead to serious illness or death.

3 Sep 2013

Researchers create specific tests to detect cancer biomarkers in patients with dermatomyositis

Researchers from major universities in the U.S. have developed specific tests to identify cancer biomarkers in patients with dermatomyositis-a systemic inflammatory disease associated with increased risk of malignancy.

3 Sep 2013

Researchers develop new model to predict treatment success more accurately

The HI virus is feared, not least, because of its great adaptability. If the virus mutates at precisely the point targeted by a drug, it is able to neutralise the attack and the treatment fails. To minimise these viral defence mechanisms, doctors treat patients with modern combination therapies involving the simultaneous administration of several drugs. This approach forces the virus to run through a series of mutations before it becomes immune to the drugs.

2 Sep 2013

Researchers pinpoint ways to counter effects of antibiotics-driven depletion of gut-dwelling bacteria

A new study by researchers at the Stanford University School of Medicine could help pinpoint ways to counter the effects of the antibiotics-driven depletion of friendly, gut-dwelling bacteria.

2 Sep 2013

Findings could alter ways in which doctors use platelets to treat traumatic injuries

A new finding could lead to novel treatments to reduce bleeding in trauma and severe infections.

2 Sep 2013

Kate Farms announces personal endorsement deals with two professional athletes

Kate Farms, the creator of Komplete Ultimate Shakes, is excited to announce personal endorsement deals with professional auto racing driver,Tristan Nunez and undefeated professional boxer, Gabino Saenz. Komplete is the world's first vegan, dairy-free, gluten-free and soy-free ready to go drink meal replacement shake available in three flavors including Vanilla Bliss, Cocoa Fudge and Jav'a Latte and can be purchased nationally at The Vitamin Shoppe.

31 Aug 2013

Small chemical changes to dietary flavonoids cause large effects on human immune system

Scientists at the University of York have discovered that very small chemical changes to dietary flavonoids cause very large effects when the plant natural products are tested for their impact on the human immune system.

31 Aug 2013

Researchers find parasitic worms limit effects of autoimmune and other diseases

If the idea of hookworms makes you shudder, consider this: Those pesky intestinal parasites may actually help your body ward off other infections, and perhaps even prevent autoimmune and other diseases.

31 Aug 2013

Research suggests clingy blood platelets may offer hope for people with rheumatoid arthritis

No one likes clingy people, but "clingy" blood platelets may offer hope for millions of people with rheumatoid arthritis. According to new research findings published in The Journal of Leukocyte Biology, a sub population of immune cells (lymphocytes) known to play a significant role in rheumatoid arthritis has platelets attached to their surface.

30 Aug 2013

Study provides first genomic characterization of remission in juvenile rheumatoid arthritis patients

More children with juvenile rheumatoid arthritis are experiencing remission of their symptoms, thanks to new biological therapies, but the remission is not well-understood. A new study published today in Arthritis Research & Therapy provides the first genomic characterization of remission in juvenile rheumatoid arthritis patients.

30 Aug 2013

Findings lead to new drugs that block cancers from spreading to bone

When a cancer cell sloughs off the edge of a tumor in the breast, it faces a tough road to survive. The cell must not only remain physically intact as it rushes through blood vessels, but it also must find a new organ to lodge itself in, take in enough nutrients and oxygen to stay alive, and begin dividing, all while escaping notice by the body's immune system.

30 Aug 2013

Immune System News and Research

New recombinant antibody can recognize MSCs in umbilical cord blood

UCLA researchers receives $13M Early Translational grants to advance innovative discoveries using stem cells

Cangene Signs Up To $77M Contract Extension With CDC

Cangene Inks Up To $77M Contract Extension With CDC

Chronic granulomatous disease (CGD) research: an interview with Dr. Griffin Rodgers, NIDDK director

VolitionRx-led consortium receives grant to develop novel NuQ biomarkers for immune response

Viralytics releases financial results for 2013

Apitope successfully completes ATX-MS-1467 Phase I trial in relapsing MS patients with positive results

Imaxio's pro-immunogenic technology used in tuberculosis vaccine phase I clinical study

Research shows how mucosal surfaces in body respond to C. albicans to prevent damage

Researchers create specific tests to detect cancer biomarkers in patients with dermatomyositis

Researchers develop new model to predict treatment success more accurately

Researchers pinpoint ways to counter effects of antibiotics-driven depletion of gut-dwelling bacteria

Findings could alter ways in which doctors use platelets to treat traumatic injuries

Kate Farms announces personal endorsement deals with two professional athletes

Small chemical changes to dietary flavonoids cause large effects on human immune system

Researchers find parasitic worms limit effects of autoimmune and other diseases

Research suggests clingy blood platelets may offer hope for people with rheumatoid arthritis

Study provides first genomic characterization of remission in juvenile rheumatoid arthritis patients

Findings lead to new drugs that block cancers from spreading to bone

Understanding the DNA Damage Response in Innate Immunity eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News